Answers are grounded in this paper and cite their sources.
Binding and unbinding rates are important characteristics of molecular interactions as they dictate binding affinities and complex lifetimes. Particularly, the engineering and maturation of nucleic acid-based ligands for therapeutic or diagnostic purposes will greatly benefit from adopting kinetic characterization in screening efforts. Here we introduce a kinetic screening setup for nucleic acid ligands based on a fluorescence biosensor platform, allowing rapid selection and kinetic characterization of aptamer sequences from random or rationally designed mutant libraries. The modular, non-covalent approach allows for a rapid and cost-effective exchange of nucleic acid ligands and automated measurements of the association and dissociation of various analytes. We screened 846 unique biomolecular interactions covered by 1774 kinetic measurements, enabling us to map essential and non-essential nucleotides in two independent aptamers, evaluate the effects of sequence variations on binding kinetics, and provide lead sequences to introduce specificity in an inherently promiscuous small molecule-binding aptamer.
No takes yet. Share an insight, caveat, or question.
Pascali et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: